BelHealth announces three promotions


BelHealth Investment Partners has made three promotions. The healthcare-focused private equity firm has promoted Joseph Wynne to chief administrative officer, Paul Barrett to vice president and Jonathan Spero to senior associate.

PRESS RELEASE

New York, NY – January 12, 2017 – BelHealth Investment Partners (“BelHealth”), a healthcare-focused private equity firm with $500 million of assets under management, announced several promotions. Joseph Wynne, current Chief Financial Officer, will now also assume the role of Chief Administrative Officer.
Paul Barrett has been promoted to Vice President and Jonathan Spero has been promoted to Senior Associate.

Mr. Wynne joined BelHealth at inception and has spent more than twenty years as a CFO in private equity, and with private equity-backed companies. He is responsible for overseeing BelHealth’s financial, compliance and administrative operations. Additionally, he provides assistance with financial due diligence on prospective investments as well as strategic, financial and operational oversight to portfolio companies. Prior to joining BelHealth, Mr. Wynne spent over ten years serving as Partner and CFO of both Commonwealth Associates and ComVest Partners, where he worked with Harold Blue. Mr. Wynne has also been an entrepreneur and served on the Boards of a number of both public and private companies.

Harold S. Blue, Founder and Managing Partner said, “I have known Joe for 20 years and he is a trusted colleague and advisor. In addition to managing the administrative and compliance team, Joe provides complementary support to our investment team and our portfolio company executives. His role is crucial to the success of our overall portfolio and he is a key member of the BelHealth senior team.”

Mr. Barrett joined BelHealth near inception and is active across all of BelHealth’s Fund I and Fund II portfolio companies. He leads BelHealth’s business development and origination efforts with the support of the investment team. He serves as team lead for BelHealth’s portfolio company AHS Staffing and serves as a Board member. Prior to joining BelHealth, Mr. Barrett served as an Associate and Analyst in CIT Group’s Healthcare Investment Banking division, where he executed M&A and leveraged finance transactions for middle market healthcare companies.

Mr. Spero joined BelHealth in March 2015 and supports current portfolio companies Apothecary by Design (“ABD”) and Care Advantage. He assisted with due diligence efforts for both platforms as well as two add-on acquisitions for ABD. Prior to joining BelHealth, Mr. Spero worked as an Analyst in the Healthcare Investment Banking division of SunTrust Robinson Humphrey where he executed M&A, equity and leveraged finance transactions.

Dennis Drislane, Managing Partner said, “Paul and Jon have both become integral members of our team. As our firm has matured, we are pleased to recognize the accomplishments of key investment team members. We are confident they will continue to thrive with increased responsibilities and develop their careers. These promotions are very well deserved and we look forward to their continued contributions to the firm.”

About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm typically invests $20-50 million per platform company across three core healthcare segments: Services, Products and Distribution. BelHealth is currently investing from Fund II, a $350 million fund.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.